欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1373/006
药品名称Pramipexol Actavis
活性成分
    • pramipexole dihydrochloride 2.62 mg
剂型Prolonged-release tablet
上市许可持有人Actavis Group PTC ehf. Reykjavíkurvegur 76-78, 220 Hafnarfjördur Iceland
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Iceland (IS)
    • Austria (AT)
    • Greece (GR)
      PRAMIPEXOLE/ACTAVIS
    • Norway (NO)
    • Finland (FI)
    • Hungary (HU)
    • Romania (RO)
      Pramipexol Actavis 2.62 mg comprimate cu eliberare prelungita
    • Slovakia (SK)
    • Malta (MT)
      Pramipexol Actavis
许可日期2015/05/26
最近更新日期2015/09/01
药物ATC编码
    • N04BC05 pramipexole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase